欣賀股份(003016.SZ)與泉州凱迪簽訂技術開發合作協議書 以開發抗病毒面料
格隆匯2月19日丨欣賀股份(003016.SZ)公佈,基於公司在後疫情時代對於健康消費市場的需求,公司將佈局功能性面料服飾市場,並推進女性健康領域的相關技術創新。
有鑑於此,公司與泉州凱迪知識產權代理事務所(普通合夥)於2023年2月簽訂了《技術開發合作協議書》,雙方本着“資源共享、優勢互補、合作共贏”原則,開發具有自主知識產權的抑菌抗菌、抗病毒、防輻射等功能性面料。同時,公司委託泉州凱迪尋求該技術領域的相關合作包括但不限於尋找領域專家撰寫或直接購買現有的成熟技術或專利。
合作方泉州凱迪將通過自身資源,協同有關高校、實驗室和第三方研發機構開發上述功能性面料的技術或生產工藝。本項目經過驗證後,泉州凱迪會以欣賀股份名義向國家知識產權主管部門申請發明專利。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.